basal cell carcinoma

Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to basal cell carcinoma: squamous cell carcinoma, melanoma

basal cell carcinoma

A slow-growing, locally invasive, but rarely metastasizing neoplasm of the skin derived from basal cells of the epidermis or hair follicles.

ba′sal cell` carcino′ma

a common and usu. curable skin cancer that arises from basal cells of the epithelium.

ba·sal cell car·ci·no·ma

n. carcinoma de célula basal, neoplasma epitelial de crecimiento moderado invasivo derivado de células basales de la epidermis o de folículos pilosos.
Mentioned in ?
References in periodicals archive ?
The US Food and Drug Administration has granted both Breakthrough Therapy Designation and Orphan Drug Designation to US-based clinical-stage biopharmaceutical company PellePharm for topical patidegib for reduction of the life-long serious clinical morbidity and disease burden of persistently developing basal cell carcinomas in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS), a rare genetic disease also known as Gorlin Syndrome, the company said.
Basal cell carcinoma displays a variety of growth patterns that may be broadly divided into nonaggressive (indolent) and aggressive types.
Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma.
The present study was aimed to know the aetiological factors and to evaluate the clinical and histopathological spectrum of basal cell carcinoma in Eastern Andhra Pradesh.
According to the Skin Cancer Foundation, basal cell carcinoma stems from abnormal, uncontrolled growths or lesions that appear in the skin's basal cells.
Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
Basal cell carcinoma (BCC) is caused by malignancy of epithelial cells located in deep epidermal layer of skin.
The report provides comprehensive information on the therapeutics under development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The European Commission has approved Swiss drug maker Novartis's Odomzo (sonidegib, formerly LDE225) 200mg capsules intended to treat adults with locally advanced basal cell carcinoma who are not amenable to curative surgery or radiation therapy.
Reconstructive rhinoplasty in cases with basal cell carcinoma of the nose.
Among these tumors, basal cell carcinomas are less common and less aggressive in nature.
This report provides comprehensive information on the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Full browser ?